Virtual Patient Perspectives Roundtable: Overcoming Barriers to Genetic Testing in Ovarian Cancer

The virtual roundtable panelists brought expertise and perspectives on genetic testing for ovarian cancer and discuss ways to we can advocate to overcome barriers, concerns, and challenges in this area.

The goals of the roundtable were:
- Discuss the value of genetic testing as it relates to preventative and treatment options
- Drive awareness to the disparities and barriers of genetic testing
- Review the European experts’ consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer
- Understand the process and importance of genetic testing
- Hear a patient’s perspective to genetic testing

Moderator - Robert Coleman (USA)
Panelists:
- Emanuela Bellet (Italy)
- Sarah Gerrard, MD, CGC (USA)
- Domenica "Ketta" Lorusso, MD, PhD (Italy)
- Asima Mukhopadhyay, MD (India)